Technology

OpenAI's extensive partnerships and Sam Altman's hints of more deals signal aggressive expansion, while the Bank of England warns of an AI stock bubble reminiscent of the dot-com era, and Sora's rapid adoption alongside ChatGPT's evolution into an operating system highlight the industry's rapid advancements and market volatility.

NASA's ongoing struggle with budget cuts juxtaposes with Stoke Space's significant investment and Blue Origin's reusability ambitions for New Glenn, while AST SpaceMobile's deal with Verizon underscores increasing commercial activity and competition in satellite communications.

TechCrunch Disrupt 2025 showcasing numerous VC judges and startup insights is a highlight, with significant funding rounds for Base Power and Charles Schwab backing Qapita, all amidst entrepreneurial showcases like Tim Draper's pitch show and Revolut's aggressive expansion into India.

FCC's decision to eliminate ISP fee listing requirements reflects a shift in regulatory burdens, while H-1B visa changes continue to impact startup talent, and criticism mounts against AI devices that listen to conversations, alongside Cards Against Humanity's creative tariff avoidance and ICE's deployment of surveillance tech.

Logitech's planned obsolescence of smart home devices and Synology's reversal on drive restrictions spark discussions on consumer rights, as Google enhances its virtual try-on shopping tools and releases the Pixel 10 Pro Fold, all while Amazon gears up for another Prime Day and Bounce introduces a tool for social media account portability.

Salesforce's refusal to pay a massive extortion demand highlights ongoing cybersecurity threats, as Elon Musk settles a significant lawsuit with former Twitter executives, and SoftBank strategically expands its robotics portfolio through acquisitions, with Ganiga showcasing waste-sorting robots.

Groundbreaking chemistry research on ordered polymers winning a Nobel prize and advancements in quantum computing with floating electrons on helium mark scientific progress, while Amazon Pharmacy expands with prescription drug vending machines, and a rare medical mystery captures attention.

Previous
Next